Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics

por ZIMONJIC, DRAZEN B., POPESCU, NICHOLAS C.
Publicado 2012

DLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctions

por Tripathi, Veenu, Popescu, Nicholas C, Zimonjic, Drazen B
Publicado 2014

Acquired genetic and functional alterations associated with transforming growth factor β type I resistance in Hep3B human hepatocellular carcinoma cell line

por Zimonjic, Drazen B, Zhou, Xiaoling, Lee, Ju-Seog, Ullmannova-Benson, Veronika, Tripathi, Veenu, Thorgeirsson, Snorri S, Popescu, Nicholas C
Publicado 2009

DLC-1:a Rho GTPase-activating protein and tumour suppressor

por Durkin, Marian E, Yuan, Bao-Zhu, Zhou, Xiaoling, Zimonjic, Drazen B, Lowy, Douglas R, Thorgeirsson, Snorri S, Popescu, Nicholas C
Publicado 2007

In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells

por Zimonjic, Drazen B, Chan, Lai N, Tripathi, Veenu, Lu, Jie, Kwon, Ohyun, Popescu, Nicholas C, Lowy, Douglas R, Tamanoi, Fuyuhiko
Publicado 2013